EdgarLookup

BridgeBio Pharma, Inc. — 10-Q Filings

20 10-Q filings on record

This page lists all 10-Q filings submitted to the SEC by BridgeBio Pharma, Inc. (BBIO), sorted by most recent first. Each row links to the full filing on EdgarLookup. BridgeBio Pharma, Inc. has filed 20 10-Q documents with the SEC since 2018. To view all SEC filings by BridgeBio Pharma, Inc., see the full filings list.

Overview All Filings Financials Insiders
All 10-K 10-Q 144 3 4 4/A 424B3 424B4 424B5 424B7 425 5 5/A 8-A12B 8-K ARS CERT CORRESP CT ORDER DEF 14A DEFA14A DEFM14A DRS DRS/A DRSLTR EFFECT PRE 14A S-1 S-1/A S-1MEF S-3ASR S-4 S-4/A S-8 SC 13D SC 13D/A SC 13G SC 13G/A SCHEDULE 13D/A SCHEDULE 13G SCHEDULE 13G/A SEC STAFF LETTER UPLOAD
Form Description Accession Number Filed Period
10-Q 10-Q 0001743881-25-000012 Oct 29, 2025 Sep 30, 2025
10-Q 10-Q 0000950170-25-103192 Aug 5, 2025 Jun 30, 2025
10-Q 10-Q 0000950170-25-060314 Apr 29, 2025 Mar 31, 2025
10-Q 10-Q 0000950170-24-124577 Nov 12, 2024 Sep 30, 2024
10-Q 10-Q 0000950170-24-089326 Aug 1, 2024 Jun 30, 2024
10-Q 10-Q 0000950170-24-052165 May 2, 2024 Mar 31, 2024
10-Q 10-Q 0000950170-23-058255 Nov 2, 2023 Sep 30, 2023
10-Q 10-Q 0000950170-23-037977 Aug 3, 2023 Jun 30, 2023
10-Q 10-Q 0000950170-23-017812 May 4, 2023 Mar 31, 2023
10-Q 10-Q 0000950170-22-021936 Nov 3, 2022 Sep 30, 2022
10-Q 10-Q 0000950170-22-014824 Aug 4, 2022 Jun 30, 2022
10-Q 10-Q 0000950170-22-007874 May 5, 2022 Mar 31, 2022
10-Q 10-Q 0000950170-21-003080 Nov 4, 2021 Sep 30, 2021
10-Q 10-Q 0001564590-21-041676 Aug 5, 2021 Jun 30, 2021
10-Q 10-Q 0001564590-21-025064 May 6, 2021 Mar 31, 2021
10-Q 10-Q 0001564590-20-051460 Nov 5, 2020 Sep 30, 2020
10-Q 10-Q 0001564590-20-039358 Aug 11, 2020 Jun 30, 2020
10-Q 10-Q 0001564590-20-025197 May 14, 2020 Mar 31, 2020
10-Q 10-Q 0001564590-19-041986 Nov 8, 2019 Sep 30, 2019
10-Q 10-Q 0001564590-19-031927 Aug 14, 2019 Jun 30, 2019